AVITA Medical (ASX:AVH,OTCQX:AVMXY), a global regenerative medicine company, today announced that key opinion leaders from five U.S. burn centers presented clinical results of the RECELL Autologous Cell Harvesting Device (RECELL System) at two U.S. burn conferences, the 31st Annual Southern Region Burn CME Conference held in Mobile, AL and the Northeast Region Burn Conference held in Cambridge, MA.

As quoted in the press release:

A health economic model calculating the cost savings advantages of treating burn patients with the RECELL System versus standard of care was presented by William Hickerson, MD, FACS, Firefighter Burn Center, Memphis, Tennessee, and University of Tennessee Health Science Center. In a presentation titled “Resource Use, Costs and Outcomes for Treatment of Severe Burns Using RECELL in the United States,” Dr. Hickerson reported that treating patients with the RECELL System alone, or in combination with widely spaced skin grafts, is projected to reduce his burn center’s costs by up to USD $21 million per year compared to conventional treatment. Major drivers of the cost savings included a decrease in length of hospital stay and a reduction in the number of surgeries and related resources (blood transfusions and dressings).

A series of presentations detailing the results from two U.S. pivotal clinical trials demonstrating the effectiveness and clinical benefits of the RECELL System were made at the Southern Region Burn Conference by James H Holmes IV, MD, FACS, Wake Forest Baptist Medical Center, and Jeffrey Carter, MD, FACS, Medical Director of University Medical Center New Orleans Burn Center and Associate Professor of Surgery at LSU Health New Orleans School of Medicine. The results were also presented by Dr. Jeffrey Wilson Shupp, MD, Director of The Burn Center at MedStar Washington Hospital Center, at the Northeast Conference.

Click here to read the full press release.